Júlia Kanaan Recuero, Joana Roberta Fitz, Andrea Abe Pereira, & Renan Rangel Bonamigo. (2023). EGFR inhibitors: Clinical aspects, risk factors and biomarkers for acneiform eruptions and other mucosal and cutaneous adverse effects. Sociedade Brasileira de Dermatologia.
Chicago Style (17th ed.) CitationJúlia Kanaan Recuero, Joana Roberta Fitz, Andrea Abe Pereira, and Renan Rangel Bonamigo. EGFR Inhibitors: Clinical Aspects, Risk Factors and Biomarkers for Acneiform Eruptions and Other Mucosal and Cutaneous Adverse Effects. Sociedade Brasileira de Dermatologia, 2023.
MLA (9th ed.) CitationJúlia Kanaan Recuero, et al. EGFR Inhibitors: Clinical Aspects, Risk Factors and Biomarkers for Acneiform Eruptions and Other Mucosal and Cutaneous Adverse Effects. Sociedade Brasileira de Dermatologia, 2023.